Mercosur bloc moves to tighten blood products quality and safety
This article was originally published in Clinica
Executive Summary
South America’s Mercosur trading bloc has been discussing technical and regulatory issues related to blood products. Brazil’s foreign affairs ministry and healthcare products regulatory agency Anvisa hosted a week of workshops in Campinas, São Paulo. The information-sharing event, which ended yesterday, was attended by teams of representatives from Argentina, Brazil, Paraguay, Uruguay and Venezuela. Its main aim was to “promote improvements in quality- and safety-assurance in this area, through tighter regulation”, according to Anvisa. The main subjects on the agenda were good manufacturing practice (GMP), national regulatory frameworks and the harmonisation of regulations across the bloc.